Author: healthprofessionalradio

Dr. Mark Allen, MD, co-founder and CEO of Elevian, developer of therapies to treat age-related diseases like stroke and diabetes, discusses the drug candidate, recombinant growth differentiation factor 11 (rGDF11) with broad therapeutic benefits demonstrated in numerous animal studies. “Science” recognized GDF11 as a top scientific breakthrough calling it “the rejuvenation factor”.

Returned guest, Dr. Maria Milla, MD, Section Chief, Nicklaus Children’s Pediatric Care Centers discusses the talk of the increase in childhood obesity due to increased anxiety and physical inactivity in children during the pandemic. Obesity leads to many chronic problems later in life including type 2 diabetes and hypertension and she talks about how providers can discuss the health impacts with parents.

Dr. Melanie Dean, Ph.D., psychologist, discusses her new book ” The Hidden Power of Emotions:  How to Activate Your Energy Field and Transform Your Life”, a culmination of 10 years of research in psychology, molecular physics, and quantum physics.  She has discovered that there is a science-backed system for tapping your intuition’s power and using it to get what you want. 

Dr. Leigh Peterson, Ph.D., Vice President of Product Development at United Therapeutics discusses data published in the “New England Journal of Medicine” (Jan 2021) on the INCREASE study evaluating Tyvaso in pulmonary hypertension associated with interstitial lung disease (PH-ILD). The INCREASE study is the first to demonstrate a clear benefit in patients with PH-ILD, a life-threatening disease with no currently FDA-approved treatments.  She talks about what’s next for Tyvaso as they look to achieve FDA approval.

John Orwin, President and CEO of Atreca, a biopharmaceutical company, discusses their drug Discovery Platform and how they are thinking differently about the fight against cancer and their part in helping to fuel the next generation of antibody-based advancements in cancer treatment. He also talks about what’s on the horizon in 2021 for Atreca’s lead candidate ATRC-101 and their additional pipeline developments.

Colon cancer is the second deadliest cancer impacting both men and women, but it’s considered preventable if caught in earlier stages when it is most treatable. As the pandemic continues, it’s important that people stay up-to-date with their screenings and are aware of the options available, including tests that can be taken from home. Boston resident and colon cancer survivor Paul joins us today to discuss his colon cancer journey, including his experience with an at-home screening test, Cologuard, and the importance of early detection and choice in screening options.

Dr. Patricia Whitley-Williams, President of the National Foundation for Infectious Diseases (NFID) discusses the persistent gaps and racial disparities in vaccination coverage. She talks about the new NFID survey findings and explains the urgent need to encourage individuals to get vaccinated against both flu and COVID-19.

Rebecca Seidel, President of the Cardiac Ablation Solutions Operating Unit at Medtronic, discusses the FDA approval of the DiamondTemp™ Ablation (DTA) system for the treatment of patients with atrial fibrillation.  This is the first FDA approved, temperature controlled, irrigated radio frequency (RF) ablation system currently available to deliver ablations.

Dr. Timothy Henry, MD, Lindner Family Distinguished Chair in Clinical Research and Medical Director of The Carl and Edyth Lindner Center for Research at The Christ Hospital discusses coronary microvascular dysfunction (CMD) a type of non-obstructive coronary artery disease that causes decreased blood flow to the heart muscle, affects the smallest arteries, and won’t always show up on a regular exam. (The condition used to be called Syndrome X, and patients were assumed to be experiencing anxiety or a psychological issue rather than a cardiac one.) He talks about the warning signs and the developing treatment options in the space.

Garrett Bain, President of EcoGen BioSciences in Grand Junction, Colorado, discusses the increased demand for CBD therapeutics.  He talks about the difference between hemp and cannabis and the associated therapeutics.  He also talks about the withdrawal of the FDA’s proposal to regulate the over-the-counter sales of CBD, and what this means to the industry.